Optimizing combination of liver-enriched transcription factors and nuclear receptors simultaneously favors ammonia and drug metabolism in liver cells (Q49663371)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 December 2017

Language	Label	Description	Also known as
English	Optimizing combination of liver-enriched transcription factors and nuclear receptors simultaneously favors ammonia and drug metabolism in liver cells	scientific article published on 15 December 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 February 2018

http://europepmc.org/abstract/MED/29253535

Optimizing combination of liver-enriched transcription factors and nuclear receptors simultaneously favors ammonia and drug metabolism in liver cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 February 2018

http://europepmc.org/abstract/MED/29253535

author name string

Yongfa Su

1

1 reference

Europe PubMed Central

PubMed publication ID

21 February 2018

http://europepmc.org/abstract/MED/29253535

Zhanfei Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

21 February 2018

http://europepmc.org/abstract/MED/29253535

Linlin Yan

3

1 reference

Europe PubMed Central

PubMed publication ID

21 February 2018

http://europepmc.org/abstract/MED/29253535

Fen Lian

4

1 reference

Europe PubMed Central

PubMed publication ID

21 February 2018

http://europepmc.org/abstract/MED/29253535

Jianhua You

5

1 reference

Europe PubMed Central

PubMed publication ID

21 February 2018

http://europepmc.org/abstract/MED/29253535

Xiaoqian Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

21 February 2018

http://europepmc.org/abstract/MED/29253535

Nanhong Tang

7

1 reference

Europe PubMed Central

PubMed publication ID

21 February 2018

http://europepmc.org/abstract/MED/29253535

language of work or name

0 references

publication date

15 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 February 2018

http://europepmc.org/abstract/MED/29253535

Experimental Cell Research

1 reference

Europe PubMed Central

PubMed publication ID

21 February 2018

http://europepmc.org/abstract/MED/29253535

362

1 reference

Europe PubMed Central

PubMed publication ID

21 February 2018

http://europepmc.org/abstract/MED/29253535

2

1 reference

Europe PubMed Central

PubMed publication ID

21 February 2018

http://europepmc.org/abstract/MED/29253535

504-514

1 reference

Europe PubMed Central

PubMed publication ID

21 February 2018

http://europepmc.org/abstract/MED/29253535

Structure and Expression of a Complementary DNA for the Nuclear Coded Precursor of Human Mitochondrial Ornithine Transcarbamylase

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Cells for bioartificial liver devices: the human hepatoma-derived cell line C3A produces urea but does not detoxify ammonia

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Cell lines: a tool for in vitro drug metabolism studies

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Development of a bioartificial liver with glutamine synthetase-transduced recombinant human hepatoblastoma cell line, HepG2.

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Stable overexpression of arginase I and ornithine transcarbamylase in HepG2 cells improves its ammonia detoxification

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2.

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved.

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Development of a whole‐cell screening system for evaluation of the human CYP1A2‐mediated metabolism

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

The bioreactor with CYP3A4- and glutamine synthetase-introduced HepG2 cells: treatment of hepatic failure dog with diazepam overdosage

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Transcription factors in liver development, differentiation, and regeneration

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Thrombin induces endothelial arginase through AP-1 activation

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Negative regulation of cyclin D3 expression by trans-cription factor c-Ets1 in umbilical cord hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Human liver fatty acid binding protein (hFABP1) gene is regulated by liver-enriched transcription factors HNF3β and C/EBPα

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Identification of Sp1 and GC-boxes as transcriptional regulators of mouse Dag1 gene promoter

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

15d-PGJ₂ decreases PGE₂ synthesis in HBx-positive liver cells by interfering EGR1 binding to mPGES-1 promoter

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Immunocytochemical localization of ornithine transcarbamylase in rat intestinal mucosa. Light and electron microscopic study

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Promoter and 11-kilobase upstream enhancer elements responsible for hepatoma cell-specific expression of the rat ornithine transcarbamylase gene

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Stable overexpression of Pregnane X receptor in HepG2 cells increases its potential for bioartificial liver application

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Compensatory changes in CYP expression in three different toxicology mouse models: CAR-null, Cyp3a-null, and Cyp2b9/10/13-null mice

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Xenobiotic-Metabolizing Cytochrome P450 Enzymes in the Human Feto-Placental Unit: Role in Intrauterine Toxicity

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Noninvasive tests of CYP3A enzymes

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

The role of individual human cytochromes P450 in drug metabolism and clinical response

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liver

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Polymorphic cytochrome P450 2D6: humanized mouse model and endogenous substrates.

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Effects of glucose and insulin on HepG2-C3A cell metabolism

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Simultaneous recovery of dual pathways for ammonia metabolism do not improve further detoxification of ammonia in HepG2 cells

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Cell based approaches for evaluation of drug-induced liver injury.

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

CCAAT/enhancer-binding protein alpha (C/EBPalpha) and hepatocyte nuclear factor 4alpha (HNF4alpha) synergistically cooperate with constitutive androstane receptor to transactivate the human cytochrome P450 2B6 (CYP2B6) gene: application to the devel

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Human liver-type arginase gene: structure of the gene and analysis of the promoter region

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

C/EBP alpha knock-in hepatocytes exhibit increased albumin secretion and urea production.

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Hypoglycemia-associated hyperammonemia caused by impaired expression of ornithine cycle enzyme genes in C/EBPalpha knockout mice.

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

PGC-1 coactivators: inducible regulators of energy metabolism in health and disease

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Transcriptional regulation of genes for ornithine cycle enzymes

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Construction and evaluation of drug-metabolizing cell line for bioartificial liver support system.

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

Long-term culture of glutamine synthetase-transfected HepG2 cells in circulatory flow bioreactor for development of a bioartificial liver

1 reference

https://api.crossref.org/works/10.1016/J.YEXCR.2017.12.015

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YEXCR.2017.12.015

1 reference

Europe PubMed Central

PubMed publication ID

21 February 2018

http://europepmc.org/abstract/MED/29253535

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 February 2018

http://europepmc.org/abstract/MED/29253535

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49663371&oldid=2227512996"